Topic 2: OUD and Co-Morbid Conditions

Alcohol use is common among patients with opioid use disorder, but how to best practices for treating co-occuring substance use is often not clear. Understanding how to screen for alcohol use disorder, education on how alcohol use impacts opioid use disorder treatment, and treatment options for co-occurring substance use is needed.

Faculty

• Devin A. Oller , MD, FACO, FASAM

Alcohol use is common among patients with opioid use disorder, but how to best practices for treating co-occuring substance use is often not clear. Understanding how to screen for alcohol use disorder, education on how alcohol use impacts opioid use disorder treatment, and treatment options for co-occurring substance use is needed.

Faculty

• Devin A. Oller , MD, FACO, FASAM

The rate of smoking is much higher in patients with opioid use disorder compared to the general population, placing patients at risk for negative health outcomes related to substance use. Many of these individuals are not offered treatment for tobacco use.

Faculty

• Laura K. Stinson , PharmD

The rate of smoking is much higher in patients with opioid use disorder compared to the general population, placing patients at risk for negative health outcomes related to substance use. Many of these individuals are not offered treatment for tobacco use.

Faculty

• Laura K. Stinson , PharmD

Practice gaps include the consistent integration of psychiatric and addiction treatment, providing trauma informed care in this setting, and utilizing addiction informed care from a neuropsychiatric perspective.  While the understanding of addiction as a disease of the brain has been widely studied and established, the stigma of addictive disorders remains a major barrier for...

Faculty

• Chris Stewart , MD

Practice gaps include the consistent integration of psychiatric and addiction treatment, providing trauma informed care in this setting, and utilizing addiction informed care from a neuropsychiatric perspective.  While the understanding of addiction as a disease of the brain has been widely studied and established, the stigma of addictive disorders remains a major barrier for...

Faculty

• Chris Stewart , MD

The treatment of substance use disorder and serious mental illness must occur concurrently to increase the chances of success in the treatment of each one.  Recognizing the presence of co-morbid psychiatric disorders and initiating...

Faculty

• Colleen Ryan , MD

The treatment of substance use disorder and serious mental illness must occur concurrently to increase chances of success in the treatment of each one.  Recognizing the presence of co-morbid psychiatric disorders and initiating...

Faculty

• Colleen Ryan , MD

Understanding the relationship between substance use disorders and HIV and hepatitis C will allow for better treatment outcomes for persons with Substance Use Disorders. Faculty

• James Grubbs , MD

Understanding the relationship between substance use disorders and HIV and hepatitis C will allow for better treatment outcomes for persons with Substance Use Disorders. 

Faculty

• James Grubbs , MD

In a time when behavioral health issues are being discussed in the media, around the watercooler, and at kitchen tables across the country, there is still a great deal of stigma concerning suicide. In this presentation we will discuss...

Faculty

• Kelly E. Ruff , LPCC-S

Several behaviors—including gambling, internet gaming, and binge eating—significantly impact the well-being of individuals, but research is lacking on the best approaches to diagnosing and managing these...

Faculty

• Devin A. Oller , MD, FACO, FASAM
• Liza B. Bastin , MD

In recent years, there has been an increase in the use and subsequent harm from synthetic substances available in “headshops” and online. Awareness of these substances and their effects is important to promote the health and safety of people who use drugs.

Faculty

• Devin A. Oller , MD, FACO, FASAM
• Liza B. Bastin , MD

Pain is often misunderstood and not adequately treated by providers. Additionally, studies have shown that there is a provider bias when treating non-white patients for chronic pain.  As a result, additional training is needed for providers treating patients with chronic pain.

Faculty

• Devin A. Oller , MD, FACO, FASAM

Pain is often misunderstood and not adequately treated by providers. Additionally, studies have shown that there is a provider bias when treating non-white patients for chronic pain.  As a result, additional training is needed for providers treating patients with chronic pain.

Faculty

• Devin A. Oller , MD, FACO, FASAM

Stimulant use, particularly methamphetamine use, has significant adverse effects on the brain and body.  As stimulant use has increased, medical consequences such as overdose and need for hospitalization are rising. Stimulant use presents unique challenges also for addiction medicine providers treating opioid use disorder. Unlike treatment for opioid use disorder, there are no...

Faculty

• Danielle Anderson , MD

Stimulant use, particularly methamphetamine use, has significant adverse effects on the brain and body.  As stimulant use has increased, medical consequences such as overdose and need for hospitalization are rising. Stimulant use presents unique challenges also for addiction medicine providers treating opioid use disorder. Unlike treatment for opioid use disorder, there are no...

Faculty

• Danielle Anderson , MD

Xylazine is a non-opioid used as a sedative for animals and is gaining emergence across the USA.  Xylazine is most often found mixed into opioids like fentanyl to extend the effects. Many individuals including healthcare professionals are not familiar with this substance and its adverse effects. This presentation will review the best practices in identifying people using...

Faculty

• Kelly S. Ramsey , MD MPH, MA FACP, DFASAM

Xylazine is a non-opioid used as a sedative for animals and is gaining emergence across the USA.  Xylazine is most often found mixed into opioids like fentanyl to extend the effects. Many individuals including healthcare professionals are not familiar with this substance and its adverse effects. This presentation will review the best practices in identifying people using...

Faculty

• Kelly S. Ramsey , MD MPH, MA FACP, DFASAM

Individuals that use opioids often use cannabinoids as well.  However, there are many unknowns Faculty

• Shanna Babalonis , PhD

There is an estimated 3.7 million adults who inject drugs in the...

Faculty

• Laura C. Fanucchi , MD, MPH

Alcohol consumption is common and with that, alcohol use disorder (AUD) is also common. It is estimated that 20% of patients admitted to the hospital have an alcohol use disorder. Learning to diagnose AUD during a hospitalization in order to effectively manage alcohol withdrawal symptoms is vital to these patient’s health. AUD is undertreated with 7.3% of adults aged 18 and...

Faculty

• Daniel T. Weaver , MD, FACP, FASAM

Alcohol consumption is common and with that, alcohol use disorder (AUD) is also common. It is estimated that 20% of patients admitted to the hospital have an alcohol use disorder. Learning to diagnose AUD during a hospitalization in order to effectively manage alcohol withdrawal symptoms is vital to these patient’s health. AUD is undertreated with 7.3% of adults aged 18 and...

Faculty

• Daniel T. Weaver , MD, FACP, FASAM